# Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis

> **NCT02919605** · PHASE2 · COMPLETED · sponsor: **Fundação de Medicina Tropical Dr. Heitor Vieira Dourado** · enrollment: 159 (actual)

## Conditions studied

- Cutaneous Leishmaniases

## Interventions

- **DRUG:** Single dose of Pentamidine
- **DRUG:** Two doses of Pentamidine
- **DRUG:** Three doses of Pentamidine

## Key facts

- **NCT ID:** NCT02919605
- **Lead sponsor:** Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02919605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02919605, "Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT02919605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*